Concentrix (CNXC) Expected to Announce Earnings on Tuesday

Concentrix (NASDAQ:CNXC) is projected to issue its Q1 2026 results before the market opens on Tuesday, March 24th. Analysts expect Concentrix to post earnings of $2.64 per share and revenue of $2.4906 billion for the quarter. Concentrix has set its Q1 2026 guidance at 2.570-2.690 EPS and its FY 2026 guidance at 11.480-12.070 EPS. Parties may review the information on the company’s upcoming Q1 2026 earning report for the latest details on the call scheduled for Tuesday, March 24, 2026 at 8:30 AM ET.

Concentrix (NASDAQ:CNXC) last issued its quarterly earnings results on Tuesday, January 13th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.93 by $0.02. The company had revenue of $2.55 billion during the quarter, compared to the consensus estimate of $2.54 billion. Concentrix had a positive return on equity of 16.91% and a negative net margin of 13.02%.Concentrix’s revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the firm posted $3.26 EPS.

Concentrix Stock Performance

Shares of NASDAQ:CNXC opened at $31.96 on Tuesday. The business has a 50-day moving average of $36.70 and a two-hundred day moving average of $41.24. The firm has a market capitalization of $1.96 billion, a PE ratio of -1.53, a P/E/G ratio of 0.33 and a beta of 0.50. Concentrix has a 12 month low of $29.35 and a 12 month high of $66.00. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.40 and a quick ratio of 1.40.

Concentrix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, February 10th. Stockholders of record on Friday, January 30th were paid a dividend of $0.36 per share. The ex-dividend date was Friday, January 30th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 4.5%. Concentrix’s dividend payout ratio (DPR) is currently -6.91%.

Insider Activity

In other Concentrix news, CEO Christopher A. Caldwell bought 1,000 shares of Concentrix stock in a transaction on Thursday, January 29th. The stock was purchased at an average cost of $37.07 per share, for a total transaction of $37,070.00. Following the completion of the purchase, the chief executive officer directly owned 362,075 shares of the company’s stock, valued at $13,422,120.25. The trade was a 0.28% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 0.90% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Concentrix

A number of hedge funds have recently bought and sold shares of CNXC. Royal Bank of Canada boosted its holdings in Concentrix by 9.5% in the 1st quarter. Royal Bank of Canada now owns 47,501 shares of the company’s stock valued at $2,643,000 after purchasing an additional 4,133 shares during the period. Goldman Sachs Group Inc. boosted its holdings in Concentrix by 75.1% during the first quarter. Goldman Sachs Group Inc. now owns 423,287 shares of the company’s stock valued at $23,552,000 after purchasing an additional 181,546 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Concentrix by 17.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 146,515 shares of the company’s stock valued at $8,152,000 after purchasing an additional 21,746 shares during the period. Focus Partners Wealth acquired a new position in shares of Concentrix in the 1st quarter worth approximately $781,000. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Concentrix by 532.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 620 shares of the company’s stock worth $34,000 after buying an additional 522 shares in the last quarter. 90.34% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on the stock. Weiss Ratings cut shares of Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a report on Thursday, January 29th. Robert W. Baird set a $52.00 price target on Concentrix in a report on Wednesday, January 14th. Wall Street Zen upgraded Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Finally, Barrington Research restated an “outperform” rating and set a $62.00 price target on shares of Concentrix in a research report on Monday, January 12th. Three equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Concentrix presently has a consensus rating of “Hold” and an average price target of $63.75.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.